Table 1. Patient Characteristics.
| Characteristics | No. of Patients (N = 428) | % |
|---|---|---|
| Sex | ||
| Female | 175 | 40.8 |
| Male | 253 | 59.2 |
| Age. years | ||
| Median | 56 | |
| Range | 18–82 | |
| ECOG PS | ||
| 0–1 | 415 | 96.9 |
| ≤2 | 13 | 3.1 |
| Tumor Types | ||
| Gastric adenocarcinoma | 133 | 31.1 |
| Non-small cell lung cancer | 94 | 22.0 |
| Colorectal adenocarcinoma | 60 | 14.0 |
| Soft tissue sarcoma | 25 | 5.8 |
| Hepatocellular carcinoma | 21 | 4.9 |
| Gastroenteropancreatic neuroendocrine tumor | 15 | 3.5 |
| Cholangiocarcinoma | 14 | 3.3 |
| Melanoma | 12 | 2.8 |
| Pancreatic adenocarcinoma | 9 | 2.1 |
| Small cell lung cancer | 5 | 1.2 |
| Gall bladder cancer | 5 | 1.2 |
| Metastatic carcinoma of unknown origin | 4 | 0.9 |
| GIST* | 4 | 0.9 |
| Thymic carcinoma | 4 | 0.9 |
| Ampulla of Vater cancer | 3 | 0.7 |
| Esophageal squamous carcinoma | 3 | 0.7 |
| Ovarian cancer | 3 | 0.7 |
| Renal cell carcinoma | 3 | 0.7 |
| Non-melanoma skin cancer | 3 | 0.7 |
| Bladder cancer | 2 | 0.5 |
| Uterine/cervix cancer | 2 | 0.5 |
| Adrenocortical carcinoma | 1 | 0.2 |
| Duodenal adenocarcinoma | 1 | 0.2 |
| Glottic cancer | 1 | 0.2 |
| Peritoneal mesothelioma | 1 | 0.2 |
| Metastatic | 428 | 100.0 |
*
Gastrointestinal stromal tumors